These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2275892)

  • 21. Use of calcium antagonists for cardiac arrhythmias.
    Singh BN; Nademanee K
    Am J Cardiol; 1987 Jan; 59(3):153B-162B. PubMed ID: 2433930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sotalol.
    Hohnloser SH; Woosley RL
    N Engl J Med; 1994 Jul; 331(1):31-8. PubMed ID: 8202100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sotalol: a breakthrough antiarrhythmic?
    Nappi JM; McCollam PL
    Ann Pharmacother; 1993 Nov; 27(11):1359-68. PubMed ID: 8286812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
    Paul T; Lehmann C; Pfammatter JP; Kallfelz HC
    Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
    Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
    Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sotalol: a new agent for the treatment of ventricular arrhythmias.
    Samoil D; Grubb BP; Temesy-Armos PN
    Am J Med Sci; 1994 Jan; 307(1):49-53. PubMed ID: 8291508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unusual induction of slow-fast atrioventricular nodal reentrant tachycardia. Report of two cases.
    Calò L; Riccardi R; Scaglione M; Caponi D; Golia P; Gaita F
    G Ital Cardiol; 1999 Nov; 29(11):1318-22. PubMed ID: 10609133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V; Mewis C; Mayer F; Seipel L
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of oral sotalol on the conduction of accessory atrioventricular pathways].
    Blanc JJ; Boschat J; Ollivier JP; Penther P
    Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1097-102. PubMed ID: 3929739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of alterations in refractoriness and conduction in the genesis of reentrant arrhythmias. Implications for antiarrhythmic effects of class III drugs.
    Wit AL; Coromilas J
    Am J Cardiol; 1993 Nov; 72(16):3F-12F. PubMed ID: 8237828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intravenous sotalol in patients with atrioventricular accessory pathways.
    Touboul P; Atallah G; Kirkorian G; Lavaud P; Mathieu MP; Dellinger A
    Am Heart J; 1987 Sep; 114(3):545-50. PubMed ID: 3630895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Accessory pathways and supraventricular tachycardia].
    Navarcíková S
    Bratisl Lek Listy; 1999 May; 100(5):263-6. PubMed ID: 10500332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of supraventricular tachycardia.
    Shakespeare CF; Anderson M; Camm AJ
    Eur Heart J; 1993 Sep; 14 Suppl E():2-8. PubMed ID: 8223750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of d-sotalol and l-sotalol on the atrioventricular node of the rabbit heart.
    Beyer T; Brachmann J; Kübler W
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):240-6. PubMed ID: 7692164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of sotalol in controlling reentrant supraventricular tachycardias.
    Millar RN
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():625-9. PubMed ID: 2275893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical therapy for patients with supraventricular tachycardia.
    Ferguson TB; Cox JL
    Cardiol Clin; 1990 Aug; 8(3):535-55. PubMed ID: 2205389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.